Back to trial details

Intake questionnaire

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

Applying to Gabrail Cancer Center Research · Canton, Ohio

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Carcinoma, Non-Small Cell Lung?
3. Are you able to travel to Canton for study visits?